Jacobs Levy Equity Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-82,139
| Closed | -$6.01M | – | 1176 |
|
2020
Q4 | $6.01M | Buy |
82,139
+69,022
| +526% | +$5.05M | 0.05% | 368 |
|
2020
Q3 | $1.02M | Buy |
+13,117
| New | +$1.02M | 0.01% | 663 |
|
2019
Q3 | – | Sell |
-18,700
| Closed | -$450K | – | 1059 |
|
2019
Q2 | $450K | Sell |
18,700
-270,839
| -94% | -$6.52M | 0.01% | 755 |
|
2019
Q1 | $7.65M | Sell |
289,539
-31,800
| -10% | -$841K | 0.11% | 249 |
|
2018
Q4 | $6.28M | Buy |
321,339
+129,410
| +67% | +$2.53M | 0.11% | 209 |
|
2018
Q3 | $3.76M | Buy |
191,929
+7,323
| +4% | +$143K | 0.05% | 374 |
|
2018
Q2 | $3.06M | Buy |
184,606
+100,106
| +118% | +$1.66M | 0.05% | 412 |
|
2018
Q1 | $1.2M | Buy |
84,500
+18,600
| +28% | +$264K | 0.02% | 597 |
|
2017
Q4 | $962K | Buy |
+65,900
| New | +$962K | 0.02% | 623 |
|